A comprehensive view of Inhalers / Sprays / Vaporizers. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Tissue & Hygiene Market Intelligence Service.
FTC escalates battle with Teva Pharmaceuticals over inhaler patents in court
Published:
March 25, 2024
by Inside Health Policy
|
FTC files an amicus brief alleging that Teva improperly listed patents on its ProAir HFA asthma inhaler in the FDA Orange Book, blocking Amneal's approval for a generic version; the FTC is seeking a court judgement to make Teva retract the patents
Published:
March 25, 2024
by FiercePharma
|
Actylis and Novo Nordisk partner to distribute pharmaceutical grade Benzalkonium Chloride in Germany, Spain, Portugal, UK, and Ireland; partnership blends manufacturing and distribution strengths to ensure quality end-to-end service
Published:
March 25, 2024
by Associated Press
|
GSK announces cap of $35 per month on U.S. patient out-of-pocket costs for its entire portfolio of asthma and COPD inhalers
Published:
March 20, 2024
by GSK Group (GlaxoSmithKline)
|
DifGen Pharmaceuticals acquires manufacturing assets of an FDA-registered facility in Florida through Aveva Drug Delivery Systems, enhancing manufacturing capabilities and portfolio diversification; company also relocates headquarters to Miramar, Florida
Published:
March 19, 2024
by PR Newswire
|
Ask us about our Tissue & Hygiene market view